Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 2Genitourinary 2

Conditions

Multiple Myeloma 103Neoplasms, Plasma Cell 11Immunoglobulin Light-chain Amyloidosis 11Recurrence 10Leukemia, Myeloid, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm, Residual 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Paraproteinemias 3Neoplasms 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Plasma Cell 2Hodgkin Disease 2Hematologic Diseases 2Corneal Diseases 2Blood Protein Disorders 2Amyloidosis 2Acute Kidney Injury 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Renal Insufficiency 1Proteostasis Deficiencies 1Primary Myelofibrosis 1Plasmacytoma 1

Interventions

daratumumab 2Urination 2Plasma Exchange 2sodium sulfate 1glucarpidase 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Stents 1Spironolactone 1Renal Dialysis 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Ischemic Preconditioning 1Hypothermia, Induced 1Hyperthermic Intraperitoneal Chemotherapy 1Hemodiafiltration 1Drug Therapy 1Cisplatin 1Cilastatin 1Antibiotic Prophylaxis 1Anesthetics 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Acute Kidney Injury × daratumumab × Clear all
NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

Brigham and Women's Hospital

Completed
20 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT06483139 2025-11-19

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Brigham and Women's Hospital

Recruiting
450 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡